Correlates of Blood Pressure and Cholesterol Level Testing Among a Socially-Disadvantaged Population in Poland
Abstract
:1. Introduction
2. Material and Methods
2.1. Study Design and Population
2.2. Study Variables
2.3. Statistical Analysis
3. Results
3.1. Characteristics of the Study Population
3.2. Correlates of Blood Pressure and Cholesterol Level Testing
4. Discussion
5. Conclusions
Author Contributions
Funding
Conflicts of Interest
References
- World Health Organization. World Health Statistics 2019: Monitoring health for the SDGs. 2019. Available online: https://www.who.int/gho/publications/world_health_statistics/2019/en/ (accessed on 20 January 2020).
- World Health Organization. World Health Statistics 2018: Monitoring health for the SDGs. 2018. Available online: https://www.who.int/gho/publications/world_health_statistics/2018/en/ (accessed on 20 January 2020).
- Catapano, A.L.; De Backer, G.; Wiklund, O.; Chapman, M.J.; Drexel, H.; Hoes, A.W.; Jennings, S.C.; Landmesser, U.; Pedersen, T.R.; Reiner, Ž.; et al. Wytyczne ESC/EAS dotyczące leczenia zaburzeń lipidowych w 2016 roku. Kardiol. Pol. 2016, 74, 1234–1318. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Townsend, N.; Nichols, M.; Scarborough, P.; Rayner, M. Cardiovascular disease in Europe—epidemiological update 2015. Eur. Heart J. 2015, 36, 2696–2705. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Piepoli, M.F.; Hoes, A.W.; Agewall, S.; Albus, C.; Brotons, C.; Catapano, A.L.; Cooney, M.; Corrà, U.; Cosyns, B.; Deaton, C.; et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice. Eur. Heart J. 2016, 37, 2315–2381. [Google Scholar] [CrossRef] [PubMed]
- Kowalewski, W.; Hebel, K. Elevated blood pressure as cardiovascular risk factor. Rocz. Pomor. Akad. Med. Szczec. 2013, 59, 18–24. [Google Scholar]
- Arnett, D.K.; Blumenthal, R.S.; Albert, M.A.; Buroker, A.B.; Goldberger, Z.D.; Hahn, E.J.; Himmelfarb, C.D.; Khera, A.; Lloyd-Jones, D.; McEvoy, J.W.; et al. 2019 ACC/ AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J. Am. Coll. Cardiol. 2019, 74, e177–e232. [Google Scholar] [CrossRef] [PubMed]
- Williams, B.; Mancia, G.; Spiering, W.; Rosei, E.A.; Azizi, M.; Burnier, M.; Clement, D.L.; Coca, A.; de Simone, G.; Dominiczak, A.; et al. Wytyczne ESC/ESH dotyczące postępowania w nadciśnieniu tętniczym (2018). Kardiol. Pol. 2019, 77, 71–159. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Raport NFZ 2019. NFZ o Zdrowiu. Nadciśnienie Tętnicze. Warszawa, 2019. Available online: https://www/nfz.gov.pl›nfz›nadcisnienie-tetnicze-raport-nfz-2019-small (accessed on 20 January 2020).
- Knieć, M.; Kujawska- Łuczak, M. Impact of lifestyle risk factors on the occurrence for hypertension. Forum Zaburzeń Metab. 2012, 3, 14–23. [Google Scholar]
- Peters, S.A.; Singhateh, Y.; Mackay, D.; Huxley, R.R.; Woodward, M. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: A systematic review and meta-analysis. Atherosclerosis 2016, 248, 123–131. [Google Scholar] [CrossRef]
- Użarowska, M.; Surman, M.; Janik, M. Dwie twarze cholesterolu: Znaczenie fizjologiczne i udział w patogenezie wybranych schorzeń. Kosm. Probl. Nauk Biol. 2018, 67, 375–390. [Google Scholar] [CrossRef] [Green Version]
- Łukaszewski, W.; Kręgielska-Narożna, M. Diagnostyka i leczenie zaburzeń lipidowych według wytycznych Europejskiego Towarzystwa Kardiologicznego (ESC) i Europejskiego Towarzystwa Miażdżycowego (EAS) z 2016 roku. Forum Zaburzeń Metab. 2018, 9, 23–35. [Google Scholar]
- Gumprecht, J. Zalecenia kliniczne dotyczące postępowania u chorych na cukrzycę 2019. Stanowisko Polskiego Towarzystwa Diabetologicznego. Diabetol. Prakt. 2019, 5, 1–110. [Google Scholar]
- Kearney, P.M.; Whelton, M.; Reynolds, K.; Muntner, P.; Whelton, P.K.; He, J. Global burden of hypertension: Analysis of worldwide data. Lancet 2005, 365, 217–223. [Google Scholar] [CrossRef]
- Tykarski, A.; Narkiewicz, K.; Gaciong, Z.; Januszewicz, A.; Litwin, M.; Kostka-Jeziorny, K. Zasady postępowania w nadciśnieniu tętniczym – 2015 rok. Wytyczne Polskiego Towarzystwa Nadciśnienia Tętniczego. Nadciśnienie Tętnicze Prakt. 2015, 1, 1–70. [Google Scholar]
- Mancia, G.; Fagard, R.; Narkiewicz, K.; Redon, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; de Backer, G.; Dominiczak, A.; et al. 2013 ESH/ESC practice guidelines for the management of arterial hypertension. Blood Press. 2014, 23, 3–16. [Google Scholar] [CrossRef]
- Tomasik, T. Prewencja chorób układu krążenia w podstawowej opiece zdrowotnej. Zdrowie Publiczne Zarządzanie 2014, 12, 338–351. [Google Scholar]
- Marcinowicz, L.; Pawlikowska, T.; Windak, A.; Chlabicz, S. Perceptions of an older patient on the role of the family doctor in health promotion: A qualitative case study. J. Med. Case Rep. 2013, 7, 57. [Google Scholar] [CrossRef] [Green Version]
- Hicks, K.K.; Murano, P.S. Viewpoint Regarding the Limited Nutrition Education Opportunities for Physicians Worldwide. Educ. Prim. Care 2016, 27, 439–442. [Google Scholar]
- Lazić, D.; Cikac, T.; Ozvacić, Z.; Cop, R. GP’s intervention in changing lifestyle behavior of adipose patients. Acta Med. Croatica 2007, 61, 7–11. [Google Scholar]
- Walewska, E.; Ścisło, L.; Szczepanik, A.M.; Nowak, A.; Gądek, M.; Machnik, K. Tobacco smoking among patients with diseases of the cardiovascular system. Pielęgniarstwo Chir. Angiol. 2015, 3, 170–175. [Google Scholar]
- Rozporządzenie Ministra Zdrowia z dnia 21 września 2016 r. w sprawie zakresu zadań lekarza podstawowej opieki zdrowotnej, pielęgniarki podstawowej opieki zdrowotnej i położnej podstawowej opieki zdrowotnej (Dz.U. z 2016, poz. 1567). Available online: https://www.sejm.gov.pl (accessed on 20 January 2020).
- Milcarz, K.; Makowiec-Dąbrowska, T.; Bąk-Romaniszyn, L.; Kaleta, D. Smoking Patterns and Smoking Cessation Willingness—a Study among Beneficiaries of Government Welfare Assistance in Poland. Int. J. Environ. Res. Public Health 2017, 14, 131. [Google Scholar] [CrossRef] [Green Version]
- Kałucka, S.; Kaleta, D.; Makowiec-Dąbrowska, T. Prevalence of Dietary Behavior and Determinants of Quality of Diet among Beneficiaries of Government Welfare Assistance in Poland. Int. J. Environ. Res. Public Health 2019, 16, 501. [Google Scholar] [CrossRef] [PubMed]
- Kaleta, D.; Kałucka, S.; Szatko, F.; Makowiec-Dąbrowska, T. Prevalence and Correlates of Physical Inactivity during Leisure-Time and Commuting among Beneficiaries of Government Welfare Assistance in Poland. Int. J. Environ. Res. Public Health 2017, 14, 1126. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Body Mass Index. Available online: http://www.euro.who.int/en/health-topics/disease-prevention/nutrition/a-healthy-lifestyle/body-mass-index-bmi (accessed on 7 February 2020).
- Lenz, T.L.; Gillespie, N.D.; Skradski, J.; Viereck, L.K.; Packard, K.A.; Monaghan, M.S. Development of a composite lifestyle index and its relationship to quality of life improvement: The CLI pilot study. ISRN Prev. Med. 2013, 2013, 1–7. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- US Department of Health and Human Services; Office of Disease Prevention and Health Promotion. Physical Activity Guidelines for Americans. 2008. Available online: http://www.health.gov/paguidelines (accessed on 7 February 2020).
- Zdrojewski, T.; Drygas, W.; Naruszewicz, M.; Kawecka-Jaszcz, K.; Jankowski, P. Nadciśnienie tętnicze w populacji ogólnej. Hipertensjologia 2015, 1–17. Available online: https://www.researchgate.net/publication/292986521_Nadcisnienie_tetnicze_w_populacji_ogolnej/ (accessed on 20 January 2020).
- Pająk, A.; Szafraniec, K.; Polak, M.; Polakowska, M.; Kozela, M.; Piotrowski, W.; Kwaśniewska, M.; Podolecka, E.; Kozakiewicz, K.; Tykarski, A.; et al. Changes in the Prevalence, Treatment, and Control of Hypercholesterolemia and Other Dyslipidemias Over 10 Years in Poland: The WOBASZ Study. Pol. Arch. Med. Wewn. 2016, 126, 642–652. [Google Scholar]
- Ettehad, D.; Emdin, C.A.; Kiran, A.; Anderson, S.G.; Callender, T.; Emberson, J.; Chalmers, J.; Rodgers, A.; Rahimi, K. Blood pressure lowering for prevention of cardiovascular disease and death: A systematic review and meta-analysis. Lancet 2016, 387, 957–967. [Google Scholar] [CrossRef] [Green Version]
- Wolf-Maier, K.; Cooper, R.S.; Kramer, H.; Banegas, J.R.; Giampaoli, S.; Joffres, M.R.; Poulter, N.; Primatesta, P.; Stegmayr, B.; Thamm, M. Hypertension treatment and control in five European countries, Canada, and the United States. Hypertension 2004, 43, 10–17. [Google Scholar] [CrossRef] [Green Version]
- Heneghan, C.; Perera, R.; Mant, D.; Glasziou, P. Hypertension guideline recommendations in general practice: Awareness, agreement, adoption, and adherence. Br. J. Gen. Pract. 2007, 57, 948–952. [Google Scholar] [CrossRef] [Green Version]
- Chobanian, A.V.; Bakris, G.L.; Black, H.R.; Cushman, W.C.; Green, L.A.; Izzo, J.L., Jr.; Jones, D.W.; Materson, B.J.; Oparil, S.; Wright, J.T., Jr.; et al. National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National High Blood Pressure Education Program Coordinating Committee The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The JNC 7 Report. JAMA 2003, 289, 2560–2572. [Google Scholar]
- Pinho Nde, A.; Pierin, A.M. Hypertension control in Brazilian publications. Arq. Bras. Cardiol. 2013, 101, e65–e73. [Google Scholar] [CrossRef]
- Martínez-Valverde, S.; Castro-Ríos, A.; Pérez-Cuevas, R.; Klunder-Klunder, M.; Salinas-Escudero, G.; Reyes-Morales, H. Effectiveness of a medical education intervention to treat hypertension in primary care. J. Eval. Clin. Pract. 2012, 18, 420–425. [Google Scholar] [CrossRef] [PubMed]
- Mancia, G.; Fagard, R.; Narkiewicz, K.; Redon, J.; Zanchetti, A.; Böhm, M.; Christiaens, T.; Cifkova, R.; De Backer, G.; Dominiczak, A.; et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 2013, 34, 2159–2219. [Google Scholar]
- Shah, S.; Hermanowski-Vosatka, A.; Gibson, K.; Ruck, R.A.; Jia, G.; Zhang, J.; Hwang, P.; Ryan, N.W.; Langdon, R.B.; Feig, P.U. Efficacy and safety of the selective 11β-HSD-1 inhibitors MK- 0736 and MK- 0916 in overweight and obese patients with hypertension. J. Am. Soc. Hypertens. 2011, 5, 166–176. [Google Scholar] [CrossRef] [PubMed]
- Leitzmann, M.F.; Park, Y.; Blair, A.; Ballard-Barbash, R.; Mouw, T.; Hollenbeck, A.R.; Schatzkin, A. Physical activity recommendations and decreased risk of mortality. Arch. Intern. Med. 2007, 167, 2453–2460. [Google Scholar] [CrossRef] [Green Version]
- Rossi, A.; Dikareva, A.; Bacon, S.L.; Daskalopoulou, S.S. The impact of physical activity on mortality in patients with high blood pressure: A systematic review. J. Hypertens. 2012, 30, 1277–1288. [Google Scholar] [CrossRef] [Green Version]
- Hurley, B.F.; Hanson, E.D.; Sheaff, A.K. Strength training as a countermeasure to aging muscle and chronic disease. Sports Med. 2001, 41, 289–306. [Google Scholar] [CrossRef]
- Piepoli, M.F.; Hoes, A.W.; Agewall, S.; Albus, C.; Brotons, C.; Catapano, A.L.; Cooney, M.T.; Corrá, U.; Cosyns, B.; Deaton, C.; et al. Wytyczne ESC dotyczące prewencji chorób układu sercowo-naczyniowego w praktyce klinicznej w 2016 roku. Kardiol. Pol. 2016, 74, 821–936. [Google Scholar] [CrossRef] [Green Version]
- Widmer, R.J.; Flammer, A.J.; Lerman, L.O.; Lerman, A. The Mediterranean Diet, its Components, and Cardiovascular Disease. Am. J. Med. 2015, 128, 229–238. [Google Scholar] [CrossRef] [Green Version]
- Doménech, M.; Roman, P.; Lapetra, J.; García de la Corte, F.J.; Sala-Vila, A.; de la Torre, R.; Corella, D.; Salas-Salvadó, J.; Ruiz-Gutiérrez, V.; Lamuela-Raventós, R.M.; et al. Mediterranean diet reduces 24-hour ambulatory blood pressure, blood glucose, and lipids: One-year randomized, clinical trial. Hypertension 2014, 64, 69–76. [Google Scholar] [CrossRef] [Green Version]
- Pechey, R.; Monsivais, P.; Ng, Y.L.; Marteau, T.M. Why don’t poor men eat fruit? Socioeconomic differences in motivations for fruit consumption. Appetite 2015, 84, 271–279. [Google Scholar] [CrossRef] [Green Version]
- Conklin, A.I.; Forouhi, N.G.; Suhrcke, M.; Surtees, P.; Wareham, N.J.; Monsivais, P. Variety more than quantity of fruit and vegetable intake varies by socioeconomic status and financial hardship. Findings from older adults in the EPIC cohort. Appetite 2014, 83, 248–255. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Dijkstra, S.C.; Neter, J.E.; Brouwer, I.A.; Huisman, M.; Visser, M. Adherence to dietary guidelines for fruit, vegetables and fish among older Dutch adults; the role of education, income and job prestige. J. Nutr. Health Aging 2014, 18, 115–121. [Google Scholar] [CrossRef] [PubMed]
- He, F.J.; Li, J.; Macgregor, G.A. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ 2013, 346, f1325. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Li, G.; Zhang, Y.; Thabane, L.; Mbuagbaw, L.; Liu, A.; Levine, M.; Holbrook, A. Effect of green tea supplementation on blood pressure among overweight and obese adults: A systematic review and meta-analysis. J. Hypertens. 2015, 33, 243–254. [Google Scholar] [CrossRef]
- Greyling, A.; Ras, R.T.; Zock, P.L.; Lorenz, M.; Hopman, M.T.; Thijssen, D.; Draijer, R. The effect of black tea on blood pressure: A systematic review with meta-analysis of randomized controlled trials. PLoS ONE 2014, 9, e103247. [Google Scholar] [CrossRef] [Green Version]
- Michota-Katulska, E.; Zegan, M.; Lepionka, M.; Kucharska, A.; Sińska, B. Dietary habits in a selected group of medical doctors. Żyw. Człow. 2016, 43, 239–249. [Google Scholar]
- Neter, J.E.; Stam, B.E.; Kok, F.J.; Grobbee, D.E.; Geleijnse, J.M. Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003, 42, 878–884. [Google Scholar] [CrossRef]
- Jarosz, M.; Rychlik, E. Obesity epidemic - what will our future look like? Gastroenterol. Pol. 2010, 17, 47–52. [Google Scholar]
- Wojtyniak, B.; Goryński, P. Raport. Sytuacja zdrowotna ludności Polski i jej uwarunkowania. NIZP-PZH. Warszawa 2018. Available online: https://www.pzh.gov.pl/najnowszy-raport-nizp-pzh-sytuacja-zdrowotna-ludnosci-polski-i-jej-uwarunkowania/ (accessed on 20 January 2020).
- Abramczyk, A. Body mass, behaviours and social/health situation in diabetes patients at the level of primary medical healthcare: A Polish national study. Kardiol. Pol. 2013, 71, 493–501. [Google Scholar] [CrossRef]
- Biswas, A.; Alvarez, A.; Mukherjee, D. Hypertension in diabetes: Optimal pharmacotherapy. Cardiovasc. Hematol. Agents Med. Chem. 2011, 9, 95–105. [Google Scholar] [CrossRef]
- Inzucchi, S.E.; Bergenstal, R.M.; Buse, J.B.; Diamant, M.; Ferrannini, E.; Nauck, M.; Peters, A.L.; Tsapas, A.; Wender, R.; Matthews, D.R. Management of hyperglycemia in type 2 diabetes, 2015: A patient-centered approach: Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2015, 38, 140–149. [Google Scholar] [CrossRef] [Green Version]
- Kotseva, K.; Wood, D.; de Bacquer, D.; de Backer, G.; Rydén, L.; Jennings, C.; Gyberg, V.; Amouyel, P.; Bruthans, J.; Conde, A.C.; et al. EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur. J. Prev. Cardiol. 2016, 23, 636–648. [Google Scholar] [CrossRef] [PubMed]
- Groppelli, A.; Giorgi, D.M.; Omboni, S.; Parati, G.; Mancia, G. Persistent blood pressure increase induced by heavy smoking. J. Hypertens. 1992, 10, 495–499. [Google Scholar] [CrossRef] [PubMed]
- Maeda, K.; Noguchi, Y.; Fukui, T. The effects of cessation from cigarette smoking on the lipid and lipoprotein profiles: A meta-analysis. Prev. Med. 2003, 37, 283–290. [Google Scholar] [CrossRef]
- Milcarz, M.; Polańska, K.; Bąk-Romaniszyn, L.; Kaleta, D. How Social Care Beneficiaries in Poland Rate Relative Harmfulness of Various Tobacco and Nicotine-Containing Products. Int. J. Environ. Res. Public Health 2017, 14, 1029. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Milcarz, M.; Polańska, K.; Bąk-Romaniszyn, L.; Kaleta, D. Tobacco Health Risk Awareness among Socially Disadvantaged People—a Crucial Tool for Smoking Cessation. Int. J. Environ. Res. Public Health 2018, 15, 2244. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Holmes, M.V.; Dale, C.E.; Zuccolo, L.; Silverwood, R.J.; Guo, Y.; Ye, Z.; Prieto- Merino, D.; Dehghan, A.; Trompet, S.; Wong, A.; et al. InterAct Consortium. Association between alcohol and cardiovascular disease: Mendelian randomisation analysis based on individual participant data. BMJ 2014, 349, g4164. [Google Scholar] [CrossRef] [Green Version]
- Waśkiewicz, A.; Sygnowska, E. Alcohol intake and cardiovascular risk factor profile in men participating in the WOBASZ study. Kardiol. Pol. 2013, 71, 359–365. [Google Scholar] [CrossRef]
- Wróblewska, J.; Klocek, M.; Czarnecka, D. Ocena spożycia wielonienasyconych kwasów tłuszczowych wśród młodych kobiet i mężczyzn chorujących na nadciśnienie tętnicze. Przegl Lek 2016, 73, 382–387. [Google Scholar]
- Połetek, K.; Pałasz, I.; Siwiec, A.; Olszanecka, A. Knowledge and practice towards home blood pressure measurements in patients with arterial hypertension. Przegl Lek 2018, 75, 442–447. [Google Scholar]
- Collins, M.; Mason, H.; O’Flaherty, M.; Guzman-Castillo, M.; Critchley, J.; Capewell, S. An economic evaluation of salt reduction policies to reduce coronary heart disease in England: A policy modeling study. Value Health 2014, 17, 517–524. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Mason, H.; Shoaibi, A.; Ghandour, R.; O’Flaherty, M.; Capewell, S.; Khatib, R.; Jabr, S.; Unal, B.; Sözmen, K.; Arfa, C.; et al. A cost effectiveness analysis of salt reduction policies to reduce coronary heart disease in four Eastern Mediterranean countries. PLoS ONE 2014, 9, e84445. [Google Scholar] [CrossRef]
- O’Keeffe, C.; Kabir, Z.; O’Flaherty, M.; Walton, J.; Capewell, S.; Perry, I.J. Modelling the impact of specific food policy options on coronary heart disease and stroke deaths in Ireland. BMJ Open 2013, 3, e002837. [Google Scholar]
- Moreira, P.V.; Baraldi, L.G.; Moubarac, J.C.; Monteiro, C.A.; Newton, A.; Capewell, S.; O’Flaherty, M. Comparing different policy scenarios to reduce the consumption of ultra-processed foods in UK: Impact on cardiovascular disease mortality using a modelling approach. PLoS ONE 2015, 10, e0118353. [Google Scholar] [CrossRef] [PubMed]
- Szymański, F.M. Standard and additional methods of blood pressure monitoring—what we should remember? Chor. Serca Naczyń 2013, 10, 243–249. [Google Scholar]
- Stead, L.F.; Buitrago, D.; Preciado, N.; Sanchez, G.; Hartmann-Boyce, J.; Lancaster, T. Physician advice for smoking cessation. Cochrane Database Syst. Rev. 2013, 5, CD000165. [Google Scholar] [CrossRef] [PubMed]
- Bonevski, B.; O’Brien, J.; Frost, S.; Yiow, L.; Oakes, W.; Barker, D. Novel setting for addressing tobacco-related disparities: A survey of community welfare organization smoking policies, practices and attitudes. Health Educ. Res. 2013, 28, 46–57. [Google Scholar] [CrossRef]
Variables | Total N = 1710 100% | Blood Pressure Testing Yes = 1114 65.1% | Cholesterol Level Testing Yes = 460 26.9% | |||
---|---|---|---|---|---|---|
N | % | N | % | N | % | |
Sex | ||||||
Male | 568 | 33.2 | 343 | 60.4 | 131 | 23.1 |
Female | 1142 | 66.8 | 771 | 67.5 | 329 | 28.8 |
Age (years) | ||||||
<30 | 194 | 11.3 | 116 | 59.8 | 27 | 13.9 |
30-39 | 725 | 42.4 | 462 | 63.7 | 165 | 22.8 |
40-49 | 578 | 33.8 | 385 | 66.6 | 192 | 33.2 |
50-59 | 213 | 12.5 | 151 | 70.9 | 76 | 35.7 |
Subjective health state | ||||||
Fair/rather fair | 1121 | 65.5 | 685 | 61.1 | 252 | 22.5 |
Neither fair nor poor | 407 | 23.8 | 300 | 73.7 | 135 | 33.2 |
Rather poor/poor | 182 | 10.6 | 129 | 70.9 | 73 | 40.1 |
Number of health problems | ||||||
0 | 231 | 13.5 | 139 | 60.2 | 44 | 19.0 |
1-3 | 900 | 52.6 | 564 | 62.7 | 227 | 25.2 |
4-6 | 448 | 26.2 | 323 | 72.1 | 141 | 38.2 |
>7 | 97 | 5.7 | 66 | 68.0 | 41 | 42.3 |
Missing data | 34 | 2.0 | 22 | 64.7 | 7 | 20.6 |
Heart attack | ||||||
Yes | 22 | 1.3 | 18 | 81.8 | 15 | 68.2 |
No | 1688 | 98.7 | 1096 | 64.9 | 445 | 26.4 |
High blood pressure | ||||||
Yes | 197 | 11.5 | 172 | 87.3 | 105 | 53.3 |
No | 1513 | 88.5 | 942 | 62.3 | 355 | 23.5 |
Total HLIDiabetes | ||||||
Yes | 42 | 2.5 | 34 | 81.0 | 27 | 64.3 |
No | 1668 | 97.5 | 1080 | 64.7 | 433 | 26.0 |
Family history of chronic diseases | ||||||
Yes | 1175 | 68.7 | 803 | 68.3 | 346 | 29.4 |
No | 318 | 18.6 | 187 | 58.8 | 58 | 18.2 |
I don’t know or missing | 217 | 12.7 | 124 | 57.1 | 56 | 25.8 |
Smoking HLI | ||||||
1 | 1071 | 62.6 | 711 | 66.4 | 308 | 28.8 |
0 | 637 | 37.3 | 402 | 63.1 | 152 | 23.9 |
Missing data | 2 | 0.1 | 1 | 50.0 | 0 | 0.0 |
Diet HLI | ||||||
1 | 160 | 9.4 | 106 | 66.3 | 53 | 33.1 |
0 | 1550 | 90.6 | 1008 | 65.0 | 407 | 26.3 |
Recreational physical activity HLI | ||||||
1 | 445 | 26.0 | 301 | 67.6 | 126 | 28.3 |
0 | 1238 | 72.4 | 798 | 64.5 | 326 | 26.3 |
Missing data | 27 | 1.6 | 15 | 55.6 | 8 | 29.6 |
Alcohol HLI | ||||||
1 | 950 | 55.6 | 634 | 66.7 | 286 | 30.1 |
0 | 694 | 40.6 | 445 | 64.1 | 162 | 23.3 |
Missing data | 66 | 3.8 | 35 | 53.0 | 12 | 18.2 |
BMI HLI | ||||||
1 | 732 | 42.8 | 491 | 67.1 | 201 | 27.5 |
0 | 978 | 57.2 | 623 | 63.7 | 259 | 26.5 |
Total HLI | ||||||
0 | 154 | 9.0 | 100 | 64.9 | 38 | 25.7 |
1 | 401 | 23.5 | 253 | 63.1 | 97 | 24.2 |
2 | 546 | 31.9 | 349 | 63.9 | 141 | 25.8 |
3 | 331 | 19.4 | 231 | 69.8 | 94 | 28.4 |
4 | 173 | 10.1 | 122 | 70.5 | 66 | 38.2 |
5 | 11 | 0.6 | 9 | 81.8 | 5 | 45.5 |
Missing data | 94 | 5.5 | 50 | 53.2 | 19 | 20.2 |
Variable | Chance of Performing Blood Pressure Testing | Chance of Performing Cholesterol Level Testing | ||||||
---|---|---|---|---|---|---|---|---|
Unadjusted Model | Adjusted Model | Unadjusted Model | Adjusted Model | |||||
OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | OR (95% CI) | p-Value | |
Sex | ||||||||
Male | 1.00 Ref. | 1.00 Ref | 1.00 Ref. | 1.00 Ref | ||||
Female | 1.36 (1.10-1.68) | 0.004 | 1.51 (1.17-1.96) | 0.002 | 1.34 (1.06-1.70) | 0.01 | 1.36 (1.02-1.81) | 0.04 |
Age (years) | ||||||||
<30 | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
30-39 | 1.17 (0.85-1.63) | >0.05 | 1.02 (0.70-1.52) | >0.05 | 1.83 (1.17-2.84) | 0.008 | 1.91 (1.13-3.25) | 0.02 |
40-49 | 1.34 (0.96-1.87) | >0.05 | 0.97 (0.64-1.48) | >0.05 | 3.08 (1.98-4.79) | <0.001 | 2.64 (1.54-4.54) | <0.001 |
50-59 | 1.62 (1.07-2.43) | 0.02 | 1.11 (0.65-1.88) | >0.05 | 3.46 (2.11-5.67) | <0.001 | 2.67 (1.44-4.95) | 0.002 |
Subjective health state | ||||||||
Fair/rather fair | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
Neither fair nor poor | 1.77 (1.38-2.28) | <0.001 | 1.54 (1.12-2.11) | 0.008 | 1.71 (1.33-2.19) | <0.001 | 1.15 (0.83-1.58) | >0.05 |
Rather poor/poor | 1.60 (1.13-2.26) | 0.008 | 1.21 (0.76-1.91) | >0.05 | 2.30 (1.66-3.20) | <0.001 | 1.38 (0.89-2.14) | >0.05 |
Number of health problems | ||||||||
0 | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
1-3 | 1.11 (0.82-1.49) | >0.05 | 1.01 (0.72-1.41) | >0.05 | 1.44 (1.00-2.06) | 0.05 | 1.26 (0.83-1.90) | >0.05 |
4-6 | 1.71 (1.22-2.39) | 0.002 | 1.16 (0.77-1.75) | >0.05 | 1.95 (1.33-2.87) | <0.001 | 1.12 (0.70-1.79) | >0.05 |
>7 | 1.39 (0.84-2.30) | >0.05 | 0.86 (0.46-1.59) | >0.05 | 3.11 (1.85-5.23) | <0.001 | 1.62 (0.86-3.00) | >0.05 |
Heart attack | ||||||||
Yes | 2.41 (0.81-7.16) | >0.05 | 1.38 (0.37-5.09) | >0.05 | 5.98 (2.42-14.77) | <0.001 | 2.98 (1.05-8.46) | 0.04 |
No | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
High blood pressure | ||||||||
Yes | 4.72 (2.99-7.46) | <0.001 | 3.92 (2.32-6.64) | <0.001 | 3.76 (2.77-5.10) | <0.001 | 2.32 (1.61-3.34) | <0.001 |
No | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
Diabetes | ||||||||
Yes | 2.63 (1.16-5.97) | 0.02 | 1.29 (0.46-3.59) | >0.05 | 5.13 (2.70-9.73) | <0.001 | 3.33 (1.49-7.47) | 0.004 |
No | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
Family history of chronic diseases | ||||||||
Yes | 1.51 (1.17-1.95) | 0.002 | 1.32 (0.99-1.75) | 0.06 | 1.87 (1.37-2.56) | <0.001 | 1.46 (1.03-2.07) | 0.03 |
No | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
Total HLI | ||||||||
0-3 | 1.00 Ref | 1.00 Ref | 1.00 Ref | 1.00 Ref | ||||
4-5 | 1.31 (0.94-1.84) | >0.05 | 1.15 (0.79-1.68) | >0.05 | 1.80 (1.31-2.48) | <0.001 | 1.67 (1.16-2.41) | 0.006 |
© 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
Share and Cite
Znyk, M.; Polańska, K.; Bąk-Romaniszyn, L.; Kaleta, D. Correlates of Blood Pressure and Cholesterol Level Testing Among a Socially-Disadvantaged Population in Poland. Int. J. Environ. Res. Public Health 2020, 17, 2123. https://doi.org/10.3390/ijerph17062123
Znyk M, Polańska K, Bąk-Romaniszyn L, Kaleta D. Correlates of Blood Pressure and Cholesterol Level Testing Among a Socially-Disadvantaged Population in Poland. International Journal of Environmental Research and Public Health. 2020; 17(6):2123. https://doi.org/10.3390/ijerph17062123
Chicago/Turabian StyleZnyk, Małgorzata, Kinga Polańska, Leokadia Bąk-Romaniszyn, and Dorota Kaleta. 2020. "Correlates of Blood Pressure and Cholesterol Level Testing Among a Socially-Disadvantaged Population in Poland" International Journal of Environmental Research and Public Health 17, no. 6: 2123. https://doi.org/10.3390/ijerph17062123
APA StyleZnyk, M., Polańska, K., Bąk-Romaniszyn, L., & Kaleta, D. (2020). Correlates of Blood Pressure and Cholesterol Level Testing Among a Socially-Disadvantaged Population in Poland. International Journal of Environmental Research and Public Health, 17(6), 2123. https://doi.org/10.3390/ijerph17062123